Institutional Ownership Prelude Therapeutics Inc (PRLD)
This table provides information about the institutional ownership of Prelude Therapeutics Inc (PRLD). We have compiled data on the 50 institutions that hold shares in the stock, with a total of 27.9 Million shares, which have been reported (via 13F filing form) to have a value of $23.4 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2025 Q2 2025 |
10,909,256
shares
|
$9.16 Million
0.32% of portfolio
|
Q2 2023
Added 8.66%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
10,123,824
shares
|
$8.5 Million
0.08% of portfolio
|
Q1 2021
Added 0.05%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
1,068,916
shares
|
$897,889
0.0% of portfolio
|
Q2 2024
Reduced 2.6%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
932,570
shares
|
$783,358
0.0% of portfolio
|
Q2 2025
Reduced 7.59%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
927,608
shares
|
$779,190
0.0% of portfolio
|
Q2 2025
Reduced 4.97%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
581,800
shares
|
$488,712
0.0% of portfolio
|
Q2 2025
Reduced 11.41%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Aug 07, 2025 Q2 2025 |
540,565
shares
|
$454,074
0.0% of portfolio
|
Q2 2025
Added 2.12%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
284,382
shares
|
$238,880
0.0% of portfolio
|
Q2 2025
Reduced 6.08%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
248,423
shares
|
$208,675
0.0% of portfolio
|
Q2 2025
Added 69.26%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Aug 14, 2025 Q2 2025 |
225,000
shares
|
$189,000
0.0% of portfolio
|
Q2 2025
Reduced 13.59%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
217,568
shares
|
$182,757
0.0% of portfolio
|
Q2 2025
Reduced 46.27%
|
|
|
Cantor Fitzgerald, L. P.
New York, NY |
Aug 14, 2025 Q2 2025 |
211,859
shares
|
$177,961
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Td Asset Management Inc
|
Jul 28, 2025 Q2 2025 |
160,652
shares
|
$134,947
0.0% of portfolio
|
Q3 2023
Added 100.0%
|
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
154,977
shares
|
$130,180
0.0% of portfolio
|
Q2 2025
Reduced 15.62%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
149,178
shares
|
$125,309
0.0% of portfolio
|
Q2 2025
Reduced 3.89%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
104,204
shares
|
$87,531
0.0% of portfolio
|
Q2 2025
Added 8.37%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
97,592
shares
|
$81,977
0.0% of portfolio
|
Q2 2025
Reduced 65.88%
|
|
|
Jane Street Group, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
91,753
shares
|
$77,072
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Aug 14, 2025 Q2 2025 |
88,500
shares
|
$74,340
0.0% of portfolio
|
Q1 2025
Reduced 20.27%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
80,845
shares
|
$67,909
0.0% of portfolio
|
Q2 2025
Reduced 29.11%
|
|
|
Shay Capital LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
75,000
shares
|
$63,000
0.01% of portfolio
|
Q2 2025
New holding
|
|
|
Gsa Capital Partners LLP
London, X0 |
Jul 22, 2025 Q2 2025 |
71,378
shares
|
$59,957
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Aug 14, 2025 Q2 2025 |
69,252
shares
|
$58,171
0.0% of portfolio
|
Q1 2025
Reduced 1.13%
|
|
|
Y Intercept (Hong Kong) LTD
|
Aug 01, 2025 Q2 2025 |
47,788
shares
|
$40,141
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
43,647
shares
|
$36,663
0.0% of portfolio
|
Q2 2025
Added 29.05%
|